Since the observation that injections of 2,3-dimer-captopropanol (BAL) benefit the neurologic symptoms 8 and, in 1 case, 9 may have benefited a patient in the "preneurologic" stage, it is of the ...

Geneva, Switzerland: The first European Clinical Practice Guidelines (CPGs) for the diagnosis and management of Wilson's disease are published today by the European Association for the Study of the ...

Wilson’s disease is a rare genetic disorder in which copper accumulates in the body. It usually affects the liver and the brain, but can also involve the kidneys, the heart and the eyes. Symptoms are ...

Please provide your email address to receive an email when new articles are posted on . Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are ...

Ultragenyx Pharmaceutical Inc. RARE announced that the FDA has cleared the Investigational New Drug (IND) application for UX701, being evaluated for the treatment of Wilson Disease. Wilson disease is ...

LONDON--(BUSINESS WIRE)--The global Wilson’s disease drugs market 2019-2023 is expected to post a CAGR of close to 6% during the forecast period, according to the latest market research report by ...

Wilson's Disease, also known as hepatolenticular degeneration, is a genetic disease involving the inability of the body to remove excess copper. Small amounts of copper are essential for normal living ...

Note: Diagnostic testing should meet conditions listed in either column labeled A, B, or C. Diagnostic tests: (A) molecular testing; or (B) slit lamp examination, serum ceruloplasmin (CP), and 24-hour ...